SAB Biotherapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
SAB Biotherapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • SAB Biotherapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 9.23M shares, a 82.4% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 9.23M -43.1M -82.4% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 9.23M -43.1M -82.4% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 9.23M -41.2M -81.7% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 9.23M +4.19M +83% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 52.3M +9.29M +21.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 52.3M +9.28M +21.6% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 50.4M +7.44M +17.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 5.04M -38.4M -88.4% Dec 31, 2022 10-K 2024-03-29
Q3 2022 43M +39.7M +1207% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 43M +38.4M +821% Jun 30, 2022 10-K 2023-04-14
Q1 2022 43M +38.5M +864% Mar 31, 2022 10-K 2023-04-14
Q4 2021 43.5M +17.5M +67.4% Dec 31, 2021 10-K/A 2023-04-28
Q3 2021 3.29M Sep 30, 2021 10-Q 2021-11-22
Q2 2021 4.67M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 4.46M Mar 31, 2021 10-Q 2021-05-21
Q4 2020 26M Dec 31, 2020 10-K/A 2023-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.